羊支原体性肺炎两标准株对抗菌药物敏感性的研究

本实验测定了环丙沙星、氧氟沙星、单诺沙星、红霉素、罗红霉素、泰勒菌素、泰妙菌素、四环素等8种药物对羊肺炎支原体两个标准株Y98和Y-goat的体外抑菌浓度以及红霉素与氧氟沙星、泰勒菌素对Y-goat和四环素与氧氟沙星、泰勒菌素对Y98的联合药敏作用。对羊肺炎支原体两个标准株对抗菌药物的敏感性进行了分析。     

羊支原体性肺炎两标准株对抗菌药物敏感性的研究

本实验测定了环丙沙星、氧氟沙星、单诺沙星、红霉素、罗红霉素、泰勒菌素、泰妙菌素、四环素等8种药物对羊肺炎支原体两个标准株Y98和Y-goat的体外抑菌浓度以及红霉素与氧氟沙星、泰勒菌素对Y-goat和四环素与氧氟沙星、泰勒菌素对Y98的联合药敏作用。对羊肺炎支原体两个标准株对抗菌药物的敏感性进行了分析。     

山羊支原体(PG-3)体外药敏试验

本试验测定了环丙沙星,氧氟沙星,单诺沙星,红霉素,罗红霉素,泰勒菌素,泰妙菌素,四环素等8种药物对山羊肺炎支原体PG-3株体外抑菌浓度以及环丙沙星与四环素、红霉素PG-3的联合药物作用。山羊支原体的单向药敏试验结果表明红霉素单药抑菌浓度(MIC)为0.078ug/mL,效果最好。联合药敏试验结果表明红霉素和四环素、环丙沙星联合作用均呈相加作用,环丙沙星和四环素为无关作用。     

山羊支原体（PG-3）体外药敏试验

本试验测定了环丙沙星，氧氟沙星，单诺沙星，红霉素，罗红霉素，泰勒菌素，泰妙茵素，四环素等8种药物对山羊肺炎支原体PG—3株体外抑茵浓度以及环丙沙星与四环素、红霉素PG—3的联合药物作用。山羊支原体的单向药敏试验结果表明红霉素单药抑菌浓度(MIC)为0．078ug／mL，效果最好。联合药敏试验结果表明红霉素和四环素、环丙沙星联合作用均呈相加作用，环丙沙星和四环素为无关作用。     

鸡毒支原体敏感药物的筛选

用泰乐菌素、强力霉素、罗红霉素、红霉素、丁胺卡那霉素、庆大霉素、环丙沙星、双氟沙星、呋喃唑酮、呋喃他酮、泰妙菌素等药物对3株鸡毒支原体进行体外抑菌试验。结果证明，它们对鸡毒支原体均有抑菌作用，但以泰乐菌素、泰妙菌素、环丙沙星和双氟沙星抑菌效果最好，达到10^-8g／L。     

家禽常见敏感药物

正1)治疗细菌全身感染的药物。头孢噻呋、阿莫西林、阿米卡星、沙拉沙星等。2)治疗败血型大肠杆菌的药物。头孢类、氟苯尼考、阿米考星、沙拉沙星、二氟沙星等。3)治疗肠炎型大肠杆菌的药物。安普霉素、新霉素、粘杆菌素、烟酸诺氟沙星、庆大霉素等。4)治疗支原体的药物。罗红霉素、泰乐菌素、泰妙菌素、替米考星、红霉素、氧氟沙星、强力霉素等。     

徐州地区羊肺炎支原体药敏试验

正为筛选出徐州地区羊支原体肺炎的敏感药物,测定了环丙沙星、氧氟沙星、替米考星、红霉素、罗红霉素、阿奇霉素、泰妙菌素、氟苯尼考等9种药物对支原体肺炎的作用,结果表明阿奇霉素、氟苯尼考高度药物敏感,泰妙菌素药物中度敏感,其它药物不敏感。本研究为徐州地区羊支原体性肺炎临床用药提供参考。羊支原体性肺炎(Mycoplasmal pneumonia of sheep and goats,MPSG)是由支原体所引起的一种高度接触性传染病,其临床特征为咳嗽、高热、渐进性消瘦,肺、胸和     

三种抗菌药体外对鸡败血支原体的敏感性

本研究测定了蒽诺沙星、泰乐菌素及土霉素对鸡败血支原体（BG44T株）的体外最小抑菌浓度（MIC）及泰乐菌素与土霉素的联合药敏作用。MIC测定采用试管两倍稀释法，联合药敏采用棋盘法，重复三次试验，以平均值作为结果。蒽诺沙星、泰乐菌素及土霉素对鸡败血支原体的MIC分别为0.025μg/ml、0.00625μg/ml和0.5μg/ml。泰乐菌素与土霉素的联合药敏试验的抑菌浓度指数为0.5，合用有协同作用。     

家禽常见药物有哪些

正治疗细菌全身感染的药物:头孢三一嗪、头孢噻呋、阿莫西林、阿米卡星、沙拉沙星等。治疗败血型大肠杆菌的药物:头孢类、氟苯尼考、阿米考星、沙拉沙星、二氟沙星等。治疗肠炎型大肠杆菌的药物:安普霉素、新霉素、粘杆菌素、烟酸诺氟沙星、庆大霉素等。治疗支原体的药物:罗红霉素、泰乐菌素、泰妙菌素、替米考星、红霉素、氧氟沙星、强力霉素等。治疗坏死性肠炎的药物:痢菌净、青霉素、林可霉素、新     

武陵地区山羊传染性胸膜肺炎的药物防治研究

为预防和控制武陵山地区山羊传染性胸膜肺炎,采用4种药物对该区山羊进行了体内预防试验和治疗试验,结果表明:泰妙菌素和红霉素对山羊传染性胸膜肺炎霉形体感染具有预防作用,且泰妙菌素和红霉素预防效果最好,环丙沙星、四环素预防作用可靠性差;用4种药物对山羊传染性胸膜肺炎自然病例和人工病例做治疗及增重试验,结果表明:与对照组相比,环丙沙星组,四环素组差异显著,增重较明显,泰妙菌素组和红霉素组差异极显著,增重非常明显。     

An investigation into the viability of broth cultures of the T1 strain of Mycoplasma mycoides sub-species mycoides.

The T1 broth vaccine against contagious bovine pleuropneumonia can only be stored for four weeks at +4 degrees C because after that time the titre of Mycoplasma mycoides sub-species mycoides falls below the minimal vaccinating dose. An investigation into the death of these organisms during the stationary growth phase was made. The culture medium in which the vaccine was prepared was found to contain adequate nutrients. Control of the pH by the addition of KOH was shown to preserve the viability of the organism: there was no drop in titre during 336 h (14 days) at 37 degrees C. Use of this technique may prove valuable as a means of preserving the viability of T1 broth vaccine.     

Mycoplasma mycoides subsp. capri and Mycoplasma mycoides subsp. mycoides LC can be grouped into a single subspecies

Mycoplasma mycoides subsp. capri and Mycoplasma mycoides subsp. mycoides LC can be combined into one taxon on the basis of several contributions on both DNA sequence and protein analyses reported in the literature. Moreover, for the differentiation and identification of mycoplasmas of the "mycoides cluster", we investigated the rpoB gene, encoding the beta-subunit of the RNA polymerase. A segment of 527 bp of the rpoB gene was amplified from 31 strains of ruminant mycoplasmas by PCR. The nucleotide sequences were determined and aligned, and accurate genetic relationships were calculated. Cluster analysis of rpoB DNA allowed species differentiation within the "mycoides cluster" and confirmed that M. mycoides subsp. capri and M. mycoides subsp. mycoides LC cannot be distinguished from each other. "Mycoplasma mycoides subsp. capri" is proposed as a common name for both subspecies.     

Molecular mechanisms of pathogenicity of Mycoplasma mycoides subsp. mycoides SC

Mycoplasma mycoides subsp. mycoides SC, the aetiological agent of contagious bovine pleuropneumonia (CBPP), is considered the most pathogenic of the Mycoplasma species. Its virulence is probably the result of a coordinated action of various components of an antigenically and functionally dynamic surface architecture. The different virulence attributes allow the pathogen to evade the host's immune defence, adhere tightly to the host cell surface, persist and disseminate in the host causing mycoplasmaemia, efficiently import energetically valuable nutrients present in the environment, and release and simultaneously translocate toxic metabolic pathway products to the host cell where they cause cytotoxic effects that are known to induce inflammatory processes and disease. This strategy enables the mycoplasma to exploit the minimal genetic information in its small genome, not only to fulfil the basic functions for its replication but also to damage host cells in intimate proximity thereby acquiring the necessary bio-molecules, such as amino acids and nucleic acid precursors, for its own biosynthesis and survival.     

Isolation and characterisation of an Indian strain of Mycoplasma mycoides subsp. mycoides type LC from a case of caprine arthritis

Isolation and characterisation of an Indian strain of Mycoplasma mycoides subsp. mycoides LC from a case of caprine arthritis is reported in the study. The isolate was identified based on biochemical, digitonin sensitivity and growth inhibition tests. The virulence of the organism was studied by pathogenicity test in mice and goat. The antigenic and genomic profile of the isolate was compared with that of the standard strain (Y-Goat). Using different sets of primers, polymerase chain reaction was employed for rapid detection of the strain.     

Contagious bovine pleuropneumonia (CBPP) caused by vaccine strain T1/44 of Mycoplasma mycoides subsp. mycoides SC

A study was carried out on four adult cattle to assess the pathogenicity of Mycoplasma mycoides subsp. mycoides SC strain T1/44, currently used as a vaccine for the control of contagious bovine pleuropneumonia (CBPP) in Namibia. Post mortem examination 9 weeks after endobronchial inoculation of the vaccine strain to three of the four animals revealed unilateral pleuropneumonic lesions, pleuritis and well-developed sequesters in two of the three inoculated animals and several small sequesters surrounded by pleuropneumonic lesions in the diaphragmatic and apical lobes in one animal. The fourth animal, which was not directly inoculated but was in close contact with the inoculated animals, revealed only an adhesion area of the lung to the ribcage. Serological examination carried out using the complement fixation test (CFT) detected positive titres in all three intubated animals and the indirect CBPP-LppQ-ELISA was positive for two of the three inoculated animals. The contact animal showed no seroconversion. M. mycoides subsp. mycoides SC was isolated from the sequesters of two of the inoculated animals. Isolation of mycoplasmas was not possible from the third inoculated animal due to heavy contamination of the samples by other bacteria, but the presence of M. mycoides subsp. mycoides SC could be evidenced by PCR from clinical samples. The identity of the T1/44 vaccine strain isolated from the sequesters of two animals was confirmed by T1/44-specific PCR analysis and by IS1296 typing using Southern blot. These results clearly show that inoculation of T1/44 vaccine via the endobronchial route can lead to CBPP.     

Disease caused by Mycoplasma mycoides subspecies mycoides LC in Hungarian goat herds

The occurrence of a goat disease caused by Mycoplasma mycoides subsp. mycoides LC in Hungary is reported. The disease occurred in two goat herds in the spring of 1999. In one herd 25% of the 4-12 weeks old kids (10 animals) while in the other herd 33% of the 6-12 weeks old kids (20 animals) became affected. The goat kids developed polyarthritis. The most severe lesions developed in the carpal joints. All animals died after 3-8 days of disease. Four dead kids were necropsied. All of them had serofibrinous and purulent polyarthritis, and in two animals bronchopneumonia, fibrinous pleuritis and meningitis were also found. In the articular exudates the presence of mycoplasmas was detected by PCR using a general mycoplasma primer. Mycoplasmas were cultured from the joints of all animals, from the abdominal parenchymal organs of two kids and from the lungs of one animal. The cultured mycoplasmas grew in strikingly large colonies, proved to be glucose positive, arginine negative and phosphatase positive, and liquefied the coagulated serum. They survived incubation at 45 degrees C for more than 24 h. Based upon their biochemical properties, the results of the immunofluorescence (IF) and growth inhibition tests and the sequence analysis of the PCR product, the cultured strains were identified as M. mycoides subsp. mycoides LC. Animals purchased in the previous autumn had been introduced to both farms. The disease may have been introduced with asymptomatic carrier animals, as earlier no similar disease had been observed at either farm.     

Experimental infections of goats with Mycoplasma mycoides subspecies mycoides, LC type

In five experiments 29 goats were infected experimentally by five different routes with a strain of Mycoplasma mycoides subspecies mycoides, LC type, isolated from a contagious caprine pleuropneumonia-like outbreak on a farm in northern Sweden. All the goats were colonised except those inoculated subcutaneously with small doses. In its pattern of pathogenicity this strain was similar to other experimentally tested strains except that peroral infection in kids produced no clinical signs. A 'contact' goat was also colonised but the clinical signs seen in it were probably due to a concomitant infection with Pasteurella haemolytica.